Ultrasound-microbubble-mediated NF-κB decoy transfection attenuates neointimal formation after arterial injury in mice

被引:38
作者
Inagaki, H
Suzuki, J
Ogawa, M
Taniyama, Y
Morishita, R
Isobe, M
机构
[1] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138519, Japan
[2] Osaka Univ, Div Clin Gene Therapy, Osaka, Japan
关键词
ultrasound; decoy; gene therapy; smooth muscle cells; arteriosclerosis;
D O I
10.1159/000089103
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Objective: Decoy transfection is a significant methodology for suppressing gene activation. The decoy can be synthesized easily; however, the major obstacle is the difficulty involved in effective in vivo delivery. Methods and Results: We used a fluorescein-labeled decoy to investigate the ultrasound-microbubble-mediated in vivo delivery in normal and injured mouse arteries. We showed that this approach could deliver the decoy into target tissues. In addition, we performed in vivo NF-kappa B decoy transfection into murine injured arteries using the ultrasound-microbubble method. Murine femoral arteries were injured using flexible wires to establish arterial injury. Pathologically, neointima/media areas in the NF-kappa B decoy transfection using ultrasound- microbubble group showed less than those in the control groups. Immunohistochemistry revealed that enhanced expression of inflammatory factors was observed in nontreated injured arteries, while the NF-kappa B decoy suppressed the expression. Conclusion: We revealed that ultrasound-microbubble delivery of the decoy is effective for transfection into target organs. We also indicated that NF-kappa B decoy transfection using this method has potential for the suppression of neointimal formation. Ultrasound-mediated transfection of the decoy can be beneficial for the clinical treatment of restenosis after coronary intervention and other cardiovascular diseases. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 20 条
[1]   Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts [J].
Azuma, H ;
Tomita, N ;
Kaneda, Y ;
Koike, H ;
Ogihara, T ;
Katsuoka, Y ;
Morishita, R .
GENE THERAPY, 2003, 10 (05) :415-425
[2]   Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway [J].
Futamatsua, H ;
Suzuki, J ;
Kosuge, H ;
Yokoseki, O ;
Kamada, M ;
Ito, H ;
Inobe, M ;
Isobe, M ;
Uede, T .
CARDIOVASCULAR RESEARCH, 2003, 59 (01) :95-104
[3]   Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients [J].
Haude, M ;
Konorza, TFM ;
Kalnins, U ;
Erglis, A ;
Saunamäki, K ;
Glogar, HD ;
Grube, E ;
Gil, R ;
Serra, A ;
Richardt, HG ;
Sick, P ;
Erbel, R .
CIRCULATION, 2003, 107 (09) :1265-1270
[4]  
Holmes D R Jr, 2001, Rev Cardiovasc Med, V2, P115
[5]   Ultrasound-mediated transfection of mammalian cells [J].
Kim, HJ ;
Greenleaf, JF ;
Kinnick, RR ;
Bronk, JT ;
Bolander, ME .
HUMAN GENE THERAPY, 1996, 7 (11) :1339-1346
[6]   RESTENOSIS AFTER SUCCESSFUL CORONARY ANGIOPLASTY IN PATIENTS WITH SINGLE-VESSEL DISEASE [J].
LEIMGRUBER, PP ;
ROUBIN, GS ;
HOLLMAN, J ;
COTSONIS, GA ;
MEIER, B ;
DOUGLAS, JS ;
KING, SB ;
GRUENTZIG, AR .
CIRCULATION, 1986, 73 (04) :710-717
[7]   MOUSE MODEL OF ARTERIAL INJURY [J].
LINDNER, V ;
FINGERLE, J ;
REIDY, MA .
CIRCULATION RESEARCH, 1993, 73 (05) :792-796
[8]  
Miller Douglas L., 2002, Somatic Cell and Molecular Genetics, V27, P115, DOI 10.1023/A:1022983907223
[9]   Nuclear factor κB:: a potential therapeutic target in atherosclerosis and thrombosis [J].
Monaco, C ;
Paleolog, E .
CARDIOVASCULAR RESEARCH, 2004, 61 (04) :671-682
[10]   Molecular therapy to inhibit NFκB activation by transcription factor decoy oligonucleotides [J].
Morishita, R ;
Tomita, N ;
Kaneda, Y ;
Ogihara, T .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (02) :139-146